Carcinoma Chemotherapy CTCAE Cellular therapy Monoclonal antibody Tyrosine kinase inhibitors (TKIs) Sarcoma TNM staging system Surgical margin Maintenance chemotherapy Cancer Multiple myeloma Recurrence or relapse Active surveillance Clinical stage Benign ECOG performance status Complete remission Refractory Adenocarcinoma Grade 3, 4, or 5 Minimal residual disease Lymphoma Adjuvant treatment Antibody drug conjugate PET scan Performance status Tumor Pathological stage Partial remission Palliation Checkpoint inhibitor Leukemia Complementary therapy Liquid tumor Cure Definitive treatment Neoadjuvant treatment Carcinoma Chemotherapy CTCAE Cellular therapy Monoclonal antibody Tyrosine kinase inhibitors (TKIs) Sarcoma TNM staging system Surgical margin Maintenance chemotherapy Cancer Multiple myeloma Recurrence or relapse Active surveillance Clinical stage Benign ECOG performance status Complete remission Refractory Adenocarcinoma Grade 3, 4, or 5 Minimal residual disease Lymphoma Adjuvant treatment Antibody drug conjugate PET scan Performance status Tumor Pathological stage Partial remission Palliation Checkpoint inhibitor Leukemia Complementary therapy Liquid tumor Cure Definitive treatment Neoadjuvant treatment
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Carcinoma
Chemotherapy
CTCAE
Cellular therapy
Monoclonal antibody
Tyrosine kinase inhibitors (TKIs)
Sarcoma
TNM staging system
Surgical margin
Maintenance chemotherapy
Cancer
Multiple myeloma
Recurrence or relapse
Active surveillance
Clinical stage
Benign
ECOG performance status
Complete remission
Refractory
Adenocarcinoma
Grade 3, 4, or 5
Minimal residual disease
Lymphoma
Adjuvant treatment
Antibody drug conjugate
PET scan
Performance status
Tumor
Pathological stage
Partial remission
Palliation
Checkpoint inhibitor
Leukemia
Complementary therapy
Liquid tumor
Cure
Definitive treatment
Neoadjuvant treatment